These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 11074395)

  • 1. Treatments for fatigue in multiple sclerosis: a rapid and systematic review.
    Brañas P; Jordan R; Fry-Smith A; Burls A; Hyde C
    Health Technol Assess; 2000; 4(27):1-61. PubMed ID: 11074395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
    Yang TT; Wang L; Deng XY; Yu G
    J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treating fatigue.
    Lapierre Y; Hum S
    Int MS J; 2007 Jun; 14(2):64-71. PubMed ID: 17686346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amantadine for fatigue in multiple sclerosis.
    Taus C; Giuliani G; Pucci E; D'Amico R; Solari A
    Cochrane Database Syst Rev; 2003; (2):CD002818. PubMed ID: 12804439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatments for fatigue associated with palliative care.
    Mücke M; ; Cuhls H; Peuckmann-Post V; Minton O; Stone P; Radbruch L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD006788. PubMed ID: 26026155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo.
    Krupp LB; Coyle PK; Doscher C; Miller A; Cross AH; Jandorf L; Halper J; Johnson B; Morgante L; Grimson R
    Neurology; 1995 Nov; 45(11):1956-61. PubMed ID: 7501140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
    Geisler MW; Sliwinski M; Coyle PK; Masur DM; Doscher C; Krupp LB
    Arch Neurol; 1996 Feb; 53(2):185-8. PubMed ID: 8639070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amantadine for fatigue in multiple sclerosis.
    Pucci E; Branãs P; D'Amico R; Giuliani G; Solari A; Taus C
    Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD002818. PubMed ID: 17253480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatments for fatigue associated with palliative care.
    Peuckmann V; Elsner F; Krumm N; Trottenberg P; Radbruch L
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006788. PubMed ID: 21069692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating fatigue in patients with MS: one step forward, one step back.
    Schwid SR; Murray TJ
    Neurology; 2005 Apr; 64(7):1111-2. PubMed ID: 15824329
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of fatigue in patients with multiple sclerosis.
    Zifko UA
    Drugs; 2004; 64(12):1295-304. PubMed ID: 15200345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of attention-deficit/hyperactivity disorder.
    Jadad AR; Boyle M; Cunningham C; Kim M; Schachar R
    Evid Rep Technol Assess (Summ); 1999 Nov; (11):i-viii, 1-341. PubMed ID: 10790990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological and non-pharmacological interventions for the management of fatigue related multiple sclerosis.
    Miller P; Soundy A
    J Neurol Sci; 2017 Oct; 381():41-54. PubMed ID: 28991714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatigue in multiple sclerosis.
    Krupp LB; Christodoulou C
    Curr Neurol Neurosci Rep; 2001 May; 1(3):294-8. PubMed ID: 11898532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue associated with multiple sclerosis: diagnosis, impact and management.
    Bakshi R
    Mult Scler; 2003 Jun; 9(3):219-27. PubMed ID: 12814166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, randomized, crossover trial of pemoline in fatigue associated with multiple sclerosis.
    Weinshenker BG; Penman M; Bass B; Ebers GC; Rice GP
    Neurology; 1992 Aug; 42(8):1468-71. PubMed ID: 1641137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ['Fatigue' in multiple sclerosis].
    Zimmermann C; Hohlfeld R
    Nervenarzt; 1999 Jun; 70(6):566-74. PubMed ID: 10412704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.
    Hawton A; Shearer J; Goodwin E; Green C
    Appl Health Econ Health Policy; 2013 Aug; 11(4):331-41. PubMed ID: 23637055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic treatments for fatigue associated with palliative care.
    Kirshbaum M
    Clin J Oncol Nurs; 2011 Aug; 15(4):438-9. PubMed ID: 21810580
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 28.